Ousia Pharma Alternatives & Competitors

12 companies similar to Ousia Pharma — Danish biotech company developing peptide-small molecule drugs for treatment of...

EraCal Therapeutics

Towards an efficacious and well-tolerated appetite-suppressant using our innovative in-viv...

6 Seed $1.13M

Basel, Switzerland

Biotechnology Health Care +1

Elixir Pharmaceuticals

Pioneering the future of metabolic disease treatment by harnessing genetic interactions to...

Series D $98.50M

Biotechnology Pharmaceutical

iN Therapeutics

의학 및 약학 연구개발업

8 Series B $40.00B

Korea South

Biotechnology Health and Wellness +1

Cybrexa Therapeutics

Changing the paradigm for cancer treatment through the development of antigen-independent...

11 Series B $44.40M

New Haven, United States

Biotechnology Health and Wellness +1

Track all Ousia Pharma competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

EOLO PHARMA

Cutting-Edge Pharmacological Treatment for Obesity

12 Venture round $4.50M

San Francisco, United Sta...

Biopharma Biotechnology +2

ILYA Pharma

Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients

15 Grant $15.79M

Uppsala, Sweden

Biotechnology Health Care +1

Alcinous Pharmaceuticals

1 Seed $600.00K

United States

Biotechnology Pharmaceutical

AFFIRMA BIOTECH SL

Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant an...

5 Venture round $1.98M

Barcelona, Spain

Biopharma Biotechnology +2

Structure Therapeutics

Developing accessible oral small molecule therapies for the treatment of chronic diseases...

219 IPO $1.79B

South San Francisco, Unit...

Biotechnology Health Care +1

Poolbeg Pharma plc

Focused on the development & commercialisation of innovative medicines. Ticker: POLB

15 Grant

London, United Kingdom

Biotechnology Pharmaceutical

Laminar Pharma

Biopharmaceutical company performing discovery, rational design and initial clinical devel...

39 $18.20M

Spain

Biotechnology Life Sciences +1

Novo Nordisk

We’re here to champion long-term health. Get updates on innovation and inspiring stories...

62491 IPO $78.19M

Denmark

Biotechnology Pharmaceutical

About Ousia Pharma

Ousia Pharma is a Danish biotech firm that focuses on developing peptide-small molecule drugs to address obesity. The company, established in 2022, is a spin-out from the University of Copenhagen and concentrates on creating novel peptide-drug conjugates for treating obesity and metabolic diseases. Ousia Pharma's uniqu...

Business keywords

Biotech, Pharmaceuticals, Obesity Treatment, Metabolic Diseases, Peptide-drug Conjugates, Synaptic Plasticity, Drug Development, Start-up, University Spin-out, Research And Development, Copenhagen, Healthcare Innovation

Frequently Asked Questions

Companies similar to Ousia Pharma include EraCal Therapeutics , Elixir Pharmaceuticals, iN Therapeutics, Cybrexa Therapeutics, EOLO PHARMA. They work in Biotechnology and Pharmaceutical and share Ousia Pharma's focus on pharmaceuticals, drug development and research and development.

Bounce Watch lists 12 companies that share Ousia Pharma's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Ousia Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Ousia Pharma Profile EraCal Therapeutics Alternatives Elixir Pharmaceuticals Alternatives iN Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Ousia Pharma on 11 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.